Spellman David A 4
4 · Akebia Therapeutics, Inc. · Filed Oct 1, 2021
Insider Transaction Report
Form 4
Spellman David A
SVP, CFO and Treasurer
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-09-30+200,000→ 200,000 totalExercise: $2.88Exp: 2031-09-30→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.